{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:06:28Z","timestamp":1761059188663,"version":"3.38.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mph.0b013e31820ee239","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:45:27Z","timestamp":1299026727000},"page":"e1-e7","source":"Crossref","is-referenced-by-count":16,"title":["Plasma Methotrexate, Red Blood Cell Methotrexate, and Red Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"34","author":[{"given":"Wanda L.","family":"Salzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi J.","family":"Winick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald H.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210227","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.31.5.833","article-title":"Intravenous methotrexate (amethopterin) therapy in the treatment of acute leukemia.","volume":"31","author":"Perrin","year":"1963","journal-title":"Pediatrics"},{"key":"R2-21-20210227","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood.V18.4.431.431","article-title":"Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate.","volume":"18","author":"Frei","year":"1961","journal-title":"Blood"},{"key":"R3-21-20210227","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00256175","article-title":"Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment.","volume":"16","author":"Schroder","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"R4-21-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00685551","article-title":"Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.","volume":"31","author":"Graham","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"R5-21-20210227","first-page":"331","article-title":"Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.","volume":"2","author":"Graham","year":"1996","journal-title":"Clin Cancer Res"},{"key":"R6-21-20210227","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00280-005-0115-3","article-title":"Pharmacodynamic properties of methotrexate and aminotrexate during weekly therapy.","volume":"57","author":"Cole","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"R7-21-20210227","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trsl.2007.08.002","article-title":"High-performance liquid chromatography separation of aminopterin-polyglutamates within red blood cells of children treated for acute lymphoblastic leukemia.","volume":"150","author":"Vijayanathan","year":"2007","journal-title":"Transl Res"},{"key":"R8-21-20210227","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3476(84)80610-1","article-title":"Methotrexate and folate content of erythrocytes in patients receiving oral versus intramuscular therapy with methotrexate.","volume":"104","author":"Kamen","year":"1984","journal-title":"J Pediatr"},{"key":"R9-21-20210227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.1981.tb07237.x","article-title":"Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.","volume":"49","author":"Kamen","year":"1981","journal-title":"Br J Haematol"},{"key":"R10-21-20210227","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","article-title":"Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint Childrens Cancer Group and Pediatric Oncology branch study.","volume":"92","author":"Balis","year":"1998","journal-title":"Blood"},{"key":"R11-21-20210227","first-page":"81","article-title":"Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.","volume":"5","author":"Evans","year":"1987","journal-title":"NCI Monogr"},{"key":"R12-21-20210227","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0145-2126(96)00127-0","article-title":"On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia.","volume":"21","author":"Seidel","year":"1997","journal-title":"Leuk Res"},{"key":"R13-21-20210227","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.1994.12.7.1383","article-title":"Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: a Pediatric Oncology Group study.","volume":"12","author":"Camitta","year":"1994","journal-title":"J Clin Oncol"},{"key":"R14-21-20210227","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/1097-0142(19811201)48:11<2427::AID-CNCR2820481115>3.0.CO;2-M","article-title":"The transport and accumulation of methotrexate in human erythrocytes.","volume":"48","author":"da Costa","year":"1981","journal-title":"Cancer"},{"key":"R15-21-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-291X(73)90949-2","article-title":"Polygammaglutamyl metabolites of methotrexate.","volume":"52","author":"Baugh","year":"1973","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-21-20210227","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1200\/JCO.1998.16.5.1712","article-title":"Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapya Pediatric Oncology Group study.","volume":"16","author":"Mahoney","year":"1998","journal-title":"J Clin Oncol"},{"key":"R17-21-20210227","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.leu.2402132","article-title":"A comparison of early intensive methotrexatemercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial.","volume":"15","author":"Lauer","year":"2001","journal-title":"Leukemia"},{"key":"R18-21-20210227","first-page":"164","article-title":"Direct radiochemical assay for serum folate: competition between 3H-folic acid and 5-methyltetrahydrofolic acid for a folate binder.","volume":"83","author":"Kamen","year":"1974","journal-title":"J Lab Clin Med"},{"key":"R19-21-20210227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0003-2697(76)80047-4","article-title":"A rapid, radiochemical-ligand binding assay for methotrexate.","volume":"70","author":"Kamen","year":"1976","journal-title":"Anal Biochem"},{"key":"R20-21-20210227","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/0006-2952(86)90458-2","article-title":"Properties of a folate binding protein (FBP) isolated from porcine kidney.","volume":"35","author":"Kamen","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"R22-21-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"R23-21-20210227","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker.","volume":"56","author":"Patrick","year":"2000","journal-title":"Biometrics"},{"key":"R24-21-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Childrens Oncology Group.","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"R25-21-20210227","first-page":"1641","article-title":"Methotrexate cytotoxicity for L5178YAsn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability.","volume":"42","author":"Keefe","year":"1982","journal-title":"Cancer Res"},{"key":"R26-21-20210227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1097-0142(19870701)60:1<5::AID-CNCR2820600103>3.0.CO;2-D","article-title":"A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 gm2 in children with acute lymphoblastic leukemia.","volume":"60","author":"Borsi","year":"1987","journal-title":"Cancer"},{"key":"R27-21-20210227","first-page":"4267","article-title":"Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.","volume":"50","author":"Rodman","year":"1990","journal-title":"Cancer Res"},{"key":"R28-21-20210227","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJM198602203140803","article-title":"Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.","volume":"314","author":"Evans","year":"1986","journal-title":"N Engl J Med"},{"key":"R29-21-20210227","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1200\/JCO.1990.8.6.1115","article-title":"MTX clearance is more important for intermediate-risk ALL.","volume":"8","author":"Evans","year":"1990","journal-title":"J Clin Oncol"},{"key":"R30-21-20210227","first-page":"4679","article-title":"Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.","volume":"36","author":"Sirotnak","year":"1976","journal-title":"Cancer Res"},{"key":"R31-21-20210227","first-page":"345","article-title":"Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.","volume":"38","author":"Sirotnak","year":"1978","journal-title":"Cancer Res"},{"key":"R32-21-20210227","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.leu.2404404","article-title":"High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.","volume":"20","author":"Skarby","year":"2006","journal-title":"Leukemia"},{"key":"R33-21-20210227","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1373\/clinchem.2005.061150","article-title":"Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: folate overrescue concept revisited.","volume":"52","author":"Sterba","year":"2006","journal-title":"Clin Chem"},{"key":"R34-21-20210227","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"R35-21-20210227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jama.2009.7","article-title":"Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.","volume":"301","author":"Yang","year":"2009","journal-title":"JAMA"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31820ee239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T03:23:29Z","timestamp":1740972209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201201000-00021"}},"subtitle":["A Report From the Children's Oncology Group"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31820ee239","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}